ClinicalTrials.Veeva

Menu

Magnetic Resonance Imaging in Cerebral Small Vessel Disease

C

Chinese PLA General Hospital (301 Hospital)

Status

Enrolling

Conditions

MRI
Cerebral Small Vessel Diseases

Treatments

Diagnostic Test: Magnetic resonance imaging

Study type

Observational

Funder types

Other

Identifiers

NCT05200377
ChinaPLAGH-Radiology

Details and patient eligibility

About

Cerebral small vessel disease (cSVD) accounts for 20% of ischemic strokes and is the most common cause of vascular cognitive impairment. Early identification of cSVD is critical for early intervention and improve clinical outcomes. Magnetic resonance imaging (MRI) may represent as a sensitive and robust tool to detect early changes in brain subtle structures and functions. The study is to investigate the comprehensive evaluation of brain structures and vascular functions by using advanced MRI technologies in early diagnosis and management of cSVD.

Full description

Cerebral small vessel disease (cSVD) accounts for 20% of ischemic strokes and is the most common cause of vascular cognitive impairment. Early identification of cSVD is critical for early intervention and improve clinical outcomes. Magnetic resonance imaging (MRI) is sensitive to change in white matter structure and subtle vascular function alternation which correlates with cognition impairments in cSVD. MRI manifestation may also represent as useful surrogate marker. Development of advanced MRI technologies promotes their invaluable application in brain and vascular qualitative and quantitative assessment. The study is to investigate the comprehensive evaluation of brain structures and vascular functions by using advanced MRI technologies in early diagnosis and management of cSVD.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical evidence of cerebral small vessel disease or MRI evidence of lacunar infarcts and white matter hyperintensity
  • No disability (modified Rankin's scale < 2)
  • No dementia (MMSE > 24 and absence of dependence in daily activities)
  • Able and willing to consent

Exclusion criteria

  • Contraindications to MRI
  • Standard MRI of bad quality due to movement artefacts
  • Pregnant
  • Unable to tolerate MRI

Trial design

300 participants in 1 patient group

Cerebral small vessel disease group
Description:
Patients with clinically and radiologically evidenced cerebral small vessel disease. Patients are grouped by severity of cerebral small vessel disease assessed by comprehensive MRI findings.
Treatment:
Diagnostic Test: Magnetic resonance imaging

Trial contacts and locations

1

Loading...

Central trial contact

Kun Cheng, M.S.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems